| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jan-Mark Edewaard CEO | XFRA Exchange | SE0013409760 ISIN |
| DE Country | 1 Employees | - Last Dividend | - Last Split | - IPO Date |
ODI Pharma AB (publ) is a prominent pharmaceutical company based out of Stockholm, Sweden, specializing in the production and distribution of pharmaceutical cannabis and cosmetics products across Europe. Established in 2018, the company has made significant strides in integrating cannabidiol (CBD) into healthcare and wellness products, catering to a growing demand for natural and effective alternatives in the pharmaceutical and cosmetic industries. Through its innovative approach and commitment to quality, ODI Pharma AB has quickly positioned itself as a key player in the European market for cannabis-infused products.
This premium product is designed to provide hydration and rejuvenation to the skin. Infused with high-quality cannabidiol, the facial cream aims to soothe, moisturize, and reduce the appearance of inflammation, offering a natural solution for maintaining healthy skin.
ODI Pharma’s facial mask is a luxurious skincare product that combines the soothing properties of CBD with other natural ingredients to nourish and revitalize the skin. Ideal for all skin types, this facial mask helps in detoxifying and clearing the skin, leaving it soft, smooth, and glowing.
The body balm is a rich, cannabinoid-packed product aimed at providing relief and hydration to the skin. Targeting dry and stressed skin areas, this balm works by deeply moisturizing and calming skin irritation, making it a perfect choice for daily skincare routines.
All these products are meticulously developed under the Kandol. brand name, available for purchase through the company's dedicated website, kandol.net. ODI Pharma AB ensures that each product meets the highest standards of quality and efficacy, leveraging the therapeutic potential of cannabidiol to offer innovative solutions in skincare and wellness.